ALK-IN-13
ALK-IN-13 is an ALK inhibitor, extracted from patent US20130225528A1, example 19[1].
Product Specifications
CAS Number
1197953-88-0
UNSPSC
12352005
Target
Anaplastic lymphoma kinase (ALK)
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/alk-in-13.html
Solubility
10 mM in DMSO
Smiles
CN1CCN(C2CCN(C3=CC=C(NC4=NC=C(Cl)C(NC5=CC=C(P(C)(C)=O)C=C5)=N4)C(OC)=C3)CC2)CC1
Molecular Formula
C29H39ClN7O2P
Molecular Weight
584.09
References & Citations
[1]Yihan Wang, et al. Phosphorus Derivatives as Kinase Inhibitors. US20130225528A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B682270-5MG 5 mg
7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
Sign In for Pricing
View Details 
E-CL-H0620-01 24 Tests
Human NT-proBNP (N-Terminal Pro-Brain Natriuretic Peptide) CLIA Kit
Sign In for Pricing
View Details E-CL-H0620-02 48 Tests
Human NT-proBNP (N-Terminal Pro-Brain Natriuretic Peptide) CLIA Kit
Sign In for Pricing
View Details E-CL-H0620-03 96 Tests
Human NT-proBNP (N-Terminal Pro-Brain Natriuretic Peptide) CLIA Kit
Sign In for Pricing
View Details 